Emergency Use Transparency Act
Summary
Emergency Use Transparency Act This bill expands existing statutory provisions requiring the Food and Drug Administration (FDA) to publish notices of authorizations, terminations, or revocations of emergency use authorizations for medical products. Specifically, the bill requires the FDA to publish such notices on its website. The bill also allows the FDA's disclosures to include a summary of data or information from additional types of submissions.
Bill status
in committee
1 of 4 stages cleared
Introduction
Dec 2021
Committee Review
Floor Vote
President
Introduced Dec 14, 2021
Last action Dec 14, 2021
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Dec 14, 2021
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Dec 14, 2021
Introduced
Introduced in Senate
upper
1 primary · 2 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Margaret Wood Hassan
DDemocratic
Co
Lisa Murkowski
RRepublican
Co
Mike Braun
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about S 3394
Scope: US
Hi! I can help you understand S 3394. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline